Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid tumors.
Andrea Varga
No relevant relationships to disclose
Monica M. Mita
Consultant or Advisory Role - Celgene (U)
Research Funding - Celgene
Jennifer J. Wu
Consultant or Advisory Role - Celgene (U)
Honoraria - Celgene
Research Funding - Celgene
John J. Nemunaitis
Research Funding - Celgene
Timothy Francis Cloughesy
Consultant or Advisory Role - Celgene (U)
Honoraria - Celgene
Research Funding - Celgene
Paul S. Mischel
Consultant or Advisory Role - Celgene (U)
Honoraria - Celgene
Research Funding - Celgene
Johanna C. Bendell
Consultant or Advisory Role - Celgene (U)
Research Funding - Celgene
Kent C. Shih
Consultant or Advisory Role - Celgene (U)
Honoraria - Celgene
Research Funding - Celgene
Luis G. Paz-Ares
Research Funding - Celgene
Amit Mahipal
Research Funding - Celgene
Jean-Pierre Delord
Research Funding - Celgene
Robin Katie Kelley
Consultant or Advisory Role - Celgene (U)
Jean-Charles Soria
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Lilly Wong
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Shuichan Xu
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Angela James
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Xiaoling Wu
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Rajesh Chopra
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Kristen Hege
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Pamela N. Munster
Consultant or Advisory Role - Celgene (U)
Research Funding - Celgene